Association of Bone Mineral Density and Dementia
暂无分享,去创建一个
F. Rivadeneira | K. Trajanoska | L. Oei | Sanne S. Mooldijk | M. Ikram | Tian Xiao | S. Ghatan | M. Ikram | M. M. Gomez
[1] D. Kiel,et al. Osteoporosis and Dementia: Establishing a Link , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] P. Geusens,et al. Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] D. Hans,et al. DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis , 2021, Endocrine.
[4] J. Carrero,et al. Kidney Function, Kidney Function Decline, and the Risk of Dementia in Older Adults , 2021, Neurology.
[5] S. Kardia,et al. Cumulative Genetic Risk and APOE ε4 Are Independently Associated With Dementia Status in a Multiethnic, Population-Based Cohort , 2021, Neurology: Genetics.
[6] S. Murata,et al. Functional Decline and Body Composition Change in Older Adults With Alzheimer Disease: A Retrospective Cohort Study at a Japanese Memory Clinic. , 2020, Alzheimer disease and associated disorders.
[7] Brenda C T Kieboom,et al. Objectives, design and main findings until 2020 from the Rotterdam Study , 2020, European Journal of Epidemiology.
[8] C. Dengler-Crish,et al. Mechanistic complexities of bone loss in Alzheimer’s disease: a review , 2020, Connective tissue research.
[9] Jae Min Kim,et al. Association between bone mineral density and brain parenchymal atrophy and ventricular enlargement in healthy individuals , 2019, Aging.
[10] M. Ikram,et al. Genetic predisposition, modifiable risk factor profile and long-term dementia risk in the general population , 2019, Nature Medicine.
[11] H. Ryu,et al. Bone mineral loss and cognitive impairment , 2018, Medicine.
[12] L. Jacob,et al. Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany. , 2018, Journal of Alzheimer's disease : JAD.
[13] R. Payne,et al. Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study , 2017, BMJ Open.
[14] M. Carrillo,et al. Research priorities to reduce the global burden of dementia by 2025 , 2016, The Lancet Neurology.
[15] Zhongheng Zhang,et al. Multiple imputation with multivariate imputation by chained equation (MICE) package. , 2016, Annals of translational medicine.
[16] Fracture as an Independent Risk Factor of Dementia: A Nationwide Population-Based Cohort Study: Erratum , 2016, Medicine.
[17] M. Boyanov. WHOLE BODY AND REGIONAL BONE MINERAL CONTENT AND DENSITY IN WOMEN AGED 20-75 YEARS. , 2016, Acta endocrinologica.
[18] J. Reginster,et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. , 2015 .
[19] M. Carrillo,et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective , 2015, Alzheimer's & Dementia.
[20] P. Vemuri,et al. Sex and gender differences in the causes of dementia: a narrative review. , 2014, Maturitas.
[21] Huadong Zhou,et al. Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer's disease. , 2014, Current Alzheimer research.
[22] E. M. Lewiecki,et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis , 2014, Osteoporosis International.
[23] Y. Minn,et al. Osteoporosis as an independent risk factor for silent brain infarction and white matter changes in men and women: the PRESENT project , 2014, Osteoporosis International.
[24] B. Liu,et al. Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function. , 2014, Bone.
[25] Molly Fox,et al. Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women , 2013, Psychoneuroendocrinology.
[26] L. Mei,et al. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N‐acetyl‐L‐cysteine , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] Po H. Lu,et al. Reduced quality-of-life ratings in mild cognitive impairment: analyses of subject and informant responses. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[28] Liang Shen,et al. Alzheimer's Disease and Risk of Hip Fracture: A Meta-Analysis Study , 2012, TheScientificWorldJournal.
[29] G. Greendale,et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: Results from the Study of Women's Health Across the Nation (SWAN) , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] W. Leslie,et al. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[31] T. Trikalinos,et al. Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis , 2011, Osteoporosis International.
[32] Claes Ohlsson,et al. Regulation of adult bone turnover by sex steroids , 2010, Journal of cellular physiology.
[33] M. Hiligsmann,et al. Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women , 2009, European Journal of Epidemiology.
[34] L. Pothuaud,et al. Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study. , 2009, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[35] A. Tenenhouse,et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents , 2008, Canadian Medical Association Journal.
[36] O. MacDougald,et al. Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.
[37] J. Janowsky,et al. Hormone replacement therapy and cognition: systematic review and meta-analysis. , 2001, JAMA.
[38] D. Drachman,et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. , 2001, Archives of neurology.
[39] A Hofman,et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study , 2000, Clinical endocrinology.
[40] A Hofman,et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. , 1998, American journal of epidemiology.
[41] H. Brodaty,et al. ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.
[42] R. Helme,et al. Bone Density, Vitamin D Nutrition, and Parathyroid Hormone Levels in Women with Dementia , 1995, Journal of the American Geriatrics Society.
[43] J. Wishart,et al. Effect of age on bone density and bone turnover in men , 1995, Clinical endocrinology.
[44] F. Mastaglia,et al. The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer's Disease. , 2019, Journal of Alzheimer's disease : JAD.
[45] Huadong Zhou,et al. Association between bone mineral density and the risk of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[46] W. Brooks,et al. Bone density and brain atrophy in early Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[47] D. Kiel,et al. Bone mineral density and the risk of Alzheimer disease. , 2005, Archives of neurology.
[48] H. Broxmeyer,et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. , 1992, Science.